Abu Dhabi's vaccine distribution hub, developed in partnership with stakeholders including Etihad Cargo, has begun operations following the arrival of the facility’s first shipments.
The hub is a key part of the United Arab Emirates' vision to strengthen global health security, ensure equitable vaccine access, and build resilient supply chains across the region, said the Department of Health (DOH) – Abu Dhabi.
Located in Khalifa Economic Zones Abu Dhabi (KEZAD) and operated by Rafed, a subsidiary of PureHealth, the hub was developed in collaboration with the DOH - Abu Dhabi, Abu Dhabi Investment Office (ADIO), GSK, AD Ports Group, Etihad Cargo, and KEZAD Group.
Activation of the hub follows a strategic agreement signed between the DoH and GSK during Abu Dhabi Global Healthcare Week in 2024 to establish regional vaccine distribution capabilities in the emirate.
The facility has become GSK’s first vaccine distribution centre in the Middle East and the fourth worldwide. The hub’s launch also marks one of the first major operational milestones under HELM – Abu Dhabi’s Life Science Cluster.
The facility is expected to distribute millions of doses annually, shortening delivery timelines across the region and improving the integrity of vaccine supply.
Etihad Cargo said that as part of the hub partnership, it is delivering dedicated logistics support through its IATA CEIV-certified PharmaLife solution.
Stanislas Brun, chief cargo officer at Etihad Airways, said: “Etihad Cargo’s participation in this initiative reflects our continued investment in healthcare logistics. Our network and specialised PharmaLife product play a critical role in transporting temperature-sensitive vaccines reliably and efficiently across the region.
"We are proud to support Abu Dhabi’s vision of becoming a global leader in life sciences and supply chain excellence.”
In 2023, Etihad Cargo launched a 'Pharma Champions' development programme to further build its pharmaceutical business.
